Jevtana® (cabazitaxel): Potential risk of incorrect dosing following preparation of Jevtana®
2013.10.29
Active substance: cabazitaxel
The company Sanofi-Aventis Deutschland GmbH calls attention to the instructions for preparation of Jevtana®.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN